Feed on
Posts
comments

Archive for January, 2010

With obesity reaching outbreak proportions in the United States, new research has bring about that an individual’s personal beliefs about the causes of weight problems are a reputable needle of whether he or she will fortify public policies designed to combat the problem.
The research, led by the Yale Set of Famous Health, found that […]

Read Full Post »

Pet owners with pat-allergic asthma who removed their pets from their homes experienced improved airway responsiveness,
required debase doses of inhaled corticosteroids (ICSs), and went in for fewer physician follow-up visits than pet owners who
kept their pets.
Researchers from Japan laboured 20 patients with newly diagnosed pet-allergic asthma who had native pets, including
hamsters, cats, dogs, and […]

Read Full Post »

Sixty-five percent of American women between the ages of 25 and 45 report having disordered eating behaviors, according to the results of a new survey by SELF Magazine in partnership with the University of North Carolina at Chapel Hill.
An additional 10 percent of women report symptoms uniform with eating disorders such as anorexia, bulimia nervosa […]

Read Full Post »

Getting to grips with the complexity of disease proteins

Drug molecules not often act barely on one protein but on protein complexes and networks. A deeper understanding of these ‘cooperative assemblies’ should lead to better targeting of drugs.
New research into how proteins in human cells interact and ‘talk’ to each other is leading to a better understanding of how drug molecules work and should […]

Read Full Post »

New smart anti-microbial approach to preventing tooth decay

Preventing cavities could one day involve the dental commensurate of a military surgical encounter. A team of researchers supported by the Public Institute of Dental and Craniofacial Research gunshot they bring into the world created a new canny anti-microbial treatment that can be chemically programmed in the laboratory to be after unserviceable and kill a […]

Read Full Post »

Psoriasis: More Than Skin Deep

Psoriasis is a chronic illness of the immune system that affects the skin. As many as 7.5 million Americans suffer from psoriasis, according to the National Institutes of Robustness. Unlike other diseases of the immune modus operandi which impress women more often than men, psoriasis occurs not far from equally in men and women.
Psoriasis is […]

Read Full Post »

Pesticides more influential in causing cancer than previously thought

New scrutinize at the University of Liverpool suggests that environmental contaminants, such as pesticides, are more influential in causing cancer than previously thought.
Previous studies in cancer causation have often concluded that exposure to carcinogenic or endocrine-disrupting chemicals, for example, organochlorines (OC) - found in pesticides and plastics - occurs at concentrations that are too low […]

Read Full Post »

American Tamiflu Stocks Sent To Unnamed Asian Country

Mike Leavitt, US Healthiness and Philanthropist Services Secretary, says US stocks of Tamiflu are being sent to a safely putting in some unnamed Asian country. He said this stratagem is to help the first secure of apologia in case a flu pandemic breaks out.
Many knockout why this sudden move was announced. Why is […]

Read Full Post »

Exercise training in ordinary people affects the activity of 500 genes

A new study from Karolinska Institutet in Stockholm shows that hundreds of genes in the thigh muscle are activated in
habitue cycle training. The study also reveals that great differences in training response may be due to the cleverness in some
people to activate their genes much more forcefully. The learning is published May 2 in FASEB […]

Read Full Post »

Spinifex secures major investment to develop pain drug

Spinifex Pharmaceuticals, an Australian despair drug development flock, today announced it has secured risk capital investment of A$12 million from GBS Venture Partners Limited, Brandon Capital Partners and Uniseed to loot the development of its pain control drug, EMA401.
The funding is in two tranches, the first $6 million has been received and the second tranche […]

Read Full Post »

Next »